Huang, Chiun-Sheng
Yang, Youngsen
Kwong, Ava
Chen, Shin-Cheh
Tseng, Ling-Ming
Liu, Mei-Ching
Shen, Kunwei
Wang, Shusen
Ng, Ting-Ying
Feng, Yi
Sun, Guofang
Yan, Iris Renfei
Shao, Zhimin
Funding for this research was provided by:
F. Hoffmann-La Roche
Article History
Received: 11 September 2020
Accepted: 24 February 2021
First Online: 15 April 2021
Declaration
:
: All authors received third-party writing assistance which was funded by F. Hoffmann-La Roche, Ltd. Chiun-Sheng Huang’s institution has received research funding from AstraZeneca, Daiichi Sankyo, Eli Lilly, MSD, Novartis, OBI Pharma, Pfizer, and Roche. He has served on advisory boards for Amgen, Astra Zeneca, Daiichi Sankyo, Eli Lilly, Pfizer, Roche. He has received travel expenses from Amgen, Astra Zeneca, Pfizer, and Roche. He has received speaker honoraria from AstraZeneca, Eli Lilly, Novartis, Pfizer, and Roche. Youngsen Yang’s institution has received research funding from Astellas, Celgene, Eli Lilly, Janssen, Mundipharma, Novartis, Ono, Orient Europharma, and Roche. Ava Kwong’s institution has received research funding from Merck, Novartis, Roche, and WKK Medical Equipment Company, Ltd. She has received speaker and/or consulting honoraria from AstraZeneca, Pfizer, Roche, and Stryker. Shin-Cheh Chen has nothing to disclose. Ling-Ming Tseng’s institution has received research funding from Novartis, Pfizer, and Roche. He has served on advisory boards for Amgen, Eli Lily, Novartis, Daiichi Sankyo, and Roche. He has received travel expenses from AstraZeneca, Novartis, Pfizer, and Roche. He has received speaker honoraria from Pfizer and Roche. Mei-Ching Liu has served on advisory boards for AstraZeneca and Roche. Kunwei Shen has nothing to disclose. Shusen Wang has nothing to disclose. Ting-Ying Ng has nothing to disclose. Yi Feng, Guofang Sun, and Iris Renfei Yan are employees of Roche (China) Holding Ltd. Zhimin Shao has nothing to disclose.
: The study protocol was approved by the institutional review board at each study site. The trial was conducted in accordance with the ethical standards of each institution and applicable national standards as well as in accordance with the amended Declaration of Helsinki.
: Informed consent forms were approved by each study site’s Institutional Review Board (IRB)/Ethical Committee (EC). Signed written informed consent forms were required of each patient before they could participate in the study. Patients could withdraw consent at any time.